OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Screening Rates for Primary Aldosteronism in Resistant Hypertension
Gilad Jaffe, Zachary Gray, Gomathi Krishnan, et al.
Hypertension (2020) Vol. 75, Iss. 3, pp. 650-659
Open Access | Times Cited: 126

Showing 26-50 of 126 citing articles:

Primary Aldosteronism in Chronic Kidney Disease: Blood Pressure Control and Kidney and Cardiovascular Outcomes After Surgical Versus Medical Management
Debbie L. Cohen, Heather Wachtel, Anand Vaidya, et al.
Hypertension (2023) Vol. 80, Iss. 10, pp. 2187-2195
Closed Access | Times Cited: 11

Diagnosis and management of primary hyperaldosteronism in patients with hypertension: a practical approach endorsed by the British and Irish Hypertension Society
Luca Faconti, Spoorthy Kulkarni, Christian Delles, et al.
Journal of Human Hypertension (2023) Vol. 38, Iss. 1, pp. 8-18
Open Access | Times Cited: 11

Health Care Challenges in the Management of Primary Aldosteronism in Southeast Asia
Norlela Sukor, Sarat Sunthornyothin, Thang Viet Tran, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 7, pp. 1718-1725
Open Access | Times Cited: 4

MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism
Gregory L. Hundemer, Anand Vaidya
European Journal of Endocrinology (2020) Vol. 183, Iss. 6, pp. R185-R196
Open Access | Times Cited: 30

High prevalence and a long delay in the diagnosis of primary aldosteronism among patients with young‐onset hypertension
Sarah Alam, Devasenathipathy Kandasamy, Alpesh Goyal, et al.
Clinical Endocrinology (2021) Vol. 94, Iss. 6, pp. 895-903
Closed Access | Times Cited: 27

Hypertension Management in Stroke Prevention
Josephine McCarthy, Jun Yang, Benjamin Clissold, et al.
Stroke (2021) Vol. 52, Iss. 10
Open Access | Times Cited: 25

Evaluation and Management of Secondary Hypertension
Harini Sarathy, Liann Abu Salman, Christopher S. Lee, et al.
Medical Clinics of North America (2022) Vol. 106, Iss. 2, pp. 269-283
Open Access | Times Cited: 19

Primary Aldosteronism and the Role of Mineralocorticoid Receptor Antagonists for the Heart and Kidneys
Jordana B. Cohen, Irina Bancos, Jenifer M. Brown, et al.
Annual Review of Medicine (2022) Vol. 74, Iss. 1, pp. 217-230
Open Access | Times Cited: 18

Underdiagnosis of Primary Aldosteronism: A Review of Screening and Detection
Mario Funes Hernandez, Vivek Bhalla
American Journal of Kidney Diseases (2023) Vol. 82, Iss. 3, pp. 333-346
Open Access | Times Cited: 10

A flexible symbolic regression method for constructing interpretable clinical prediction models
William La Cava, Paul C. Lee, Imran Thariq Ajmal, et al.
npj Digital Medicine (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 10

Shifting paradigms in primary aldosteronism: reconsideration of screening strategy via integrating pathophysiological insights
Takumi Kitamoto, Yutaro Ruike, Hisashi Koide, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access

Renal Dysfunction in Primary Aldosteronism: How, When, and Who?
Michael Kitlinski, Karl Dreja, Zbigniew Heleniak, et al.
Kidney and Dialysis (2025) Vol. 5, Iss. 1, pp. 3-3
Open Access

Adrenal aldosterone synthase (CYP11B2) histopathology and its association with disease-induced sudden death: a cross-sectional study
Antero Ylänen, Juhani Isojärvi, Antti Virtanen, et al.
The Lancet Regional Health - Europe (2025) Vol. 51, pp. 101226-101226
Closed Access

Nationwide, Pragmatic, Direct-to-Patient Primary Aldosteronism Testing Program
Jenifer M. Brown, Laura C Tsai, E Abel, et al.
Hypertension (2025)
Closed Access

Is It Possible to Screen for Primary Aldosteronism Effectively in Primary Care?
Harsha Dissanayake, Bronwen E Warner, Anne Marie Hannon, et al.
Clinical Endocrinology (2025)
Open Access

Screening for primary aldosteronism in 1,181 Swedish primary care patients with hypertension
Nikita Makhnov, Jakob Skov, Tobias Åkerström, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access

Advances in the biochemical diagnostics of primary aldosteronism: from immunoassays to steroidomics and proteomics
Alicja Szatko, Agata Toboła, Henrik Falhammar, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access

Mineralocorticoid Receptor Antagonist Use in Hypertension to Prevent Heart Failure
Bertram Pitt, Anand Vaidya
JACC Heart Failure (2025)
Closed Access

Screening for primary aldosteronism is underutilised in patients with chronic kidney disease
Karanjeet Chauhan, Eitan Schachna, Renata Libianto, et al.
Journal of Nephrology (2022) Vol. 35, Iss. 6, pp. 1667-1677
Open Access | Times Cited: 14

High Prevalence of Autonomous Aldosterone Production in Hypertension: How to Identify and Treat It
Taweesak Wannachalee, Leedor Lieberman, Adina F. Turcu
Current Hypertension Reports (2022) Vol. 24, Iss. 5, pp. 123-132
Closed Access | Times Cited: 13

Prevalence and clinical characteristics of primary aldosteronism in a tertiary-care center in Korea
Minjae Yoon, Namki Hong, Jaehyung Ha, et al.
Hypertension Research (2022) Vol. 45, Iss. 9, pp. 1418-1429
Closed Access | Times Cited: 13

Scroll to top